Comprehensive Guide to Systemic and Topical Antifungal Pharmacology
Classification and Mechanisms of Antifungal Agents
Antifungal medications are categorized based on their site of action and their method of administration. The primary sites of action include the cell membrane, the mitotic spindle, DNA polymerase, the cell wall, and protein synthesis machinery. Drugs acting on the fungal cell membrane include Polyenes like Amphotericin B, Azoles such as Fluconazole, and Allylamines like Terbinafine. Griseofulvin, belonging to the heterocyclic benzofuran group, specifically targets the mitotic spindle to inhibit fungal growth. 5-Flucytosine targets DNA polymerase to disrupt nucleic acid synthesis. The Echinocandin class, including drugs like Caspofungin, acts on the fungal cell wall. Tavaborole is a specialized drug that inhibits protein synthesis by targeting leucyl-tRNA synthase.
From a clinical perspective, these drugs are further classified into three main delivery groups: topical agents, systemic drugs used for local actions, and systemic drugs used for systemic infections. Topical agents are applied directly to the skin, hair, or nails to treat dermatophytosis, also known as Tinea infections. Systemic drugs used for local action, such as Terbinafine and Griseofulvin, are administered orally but selectively concentrate in keratin-rich tissues like the skin, hair, and nails due to their high affinity for these areas. Systemic drugs for systemic infections are generally used for deep-seated or disseminated fungal diseases and include agents like Amphotericin B, Azoles, and Echinocandins.
Topical Antifungal Agents and Nail Lacquers
Topical antifungal drugs are widely used for treating dermatophytosis of the skin, hair, and nails. Key agents include Ciclopirox olamine, several Azoles (such as Econazole, Miconazole, and Clotrimazole), Amorolfine, Terbinafine, and Tavaborole. Within the Azole group, newer agents provide additional benefits. Sertaconazole possesses both anti-inflammatory and anti-pruritic (anti-itching) properties. Luliconazole is distinguished by its long-acting profile, while Efinaconazole is a more recent addition to the topical armamentarium.
Fungal infections of the nails, specifically Tinea unguium, often require specialized formulations known as nail lacquers or nail paints to penetrate the nail plate. Five drugs are specifically available in this format: Ciclopirox olamine, Efinaconazole, Amorolfine, Terbinafine, and Tavaborole. Ciclopirox olamine has a very high affinity for trivalent cations, which allows it to inhibit cytochrome oxidase and other enzymes that depend on these cations. Amorolfine binds to fungal membranes and inhibits the formation of ergosterol by binding to a site distinct from where Azoles act, leading to an increase in ignosterol synthesis. Tavaborole possesses a unique boron-based mechanism, forming a bond with leucyl-tRNA synthase to inhibit fungal protein synthesis.
Systemic Drugs for Local Action: Allylamines and Griseofulvin
Allylamines, including Terbinafine, Butenafine, and Naftifine, are fungicidal agents available in both oral and topical forms. Their mechanism involves the inhibition of the enzyme squalene epoxidase. This inhibition leads to an accumulation of squalene within the fungal cell, which is toxic and causes cell death. After oral absorption, these drugs selectively accumulate in keratin-rich areas. Because of this property, Allylamines are considered the drug of choice (DOC) for fungal infections of the skin, nails, and hair, collectively referred to as dermatophytosis or Tinea infections.
Griseofulvin is a heterocyclic benzofuran that acts as a fungistatic drug by disrupting the mitotic spindle, thereby preventing fungal cell division. It is administered orally and its absorption is significantly increased when taken with fatty food. Like Allylamines, Griseofulvin has a high affinity for keratin and is used for dermatophytosis. However, it must be avoided in patients who consume alcohol because it can cause a Disulfiram-like reaction.
Systemic Drugs for Systemic Infections: Polyenes
Polyenes are a class of systemic antifungal drugs that include Amphotericin B, Nystatin, and Hamycin. Their mechanism of action involves binding to ergosterol in the fungal cell membrane. This binding creates pores in the membrane, through which intracellular contents leak out, leading to fungal death. This mechanism makes Polyenes fungicidal.
Amphotericin B (AMB) is a wide-spectrum antifungal used for serious fungal infections. It is the drug of choice for Cryptococcal meningitis (acute phase), Mucormycosis, and Kala azar. It is typically administered intravenously (IV). AMB is associated with several adverse effects. Dose-independent side effects include infusion-related reactions, which are the most common (MC), manifesting as chills and fever. Dose-dependent side effects include nephrotoxicity, specifically Renal Tubular Acidosis (RTA) accompanied by hypokalemia; this is the most common dose-dependent complication. Other side effects include Bone Marrow (BM) suppression, leading to anemias. Liposomal Amphotericin B is a lipid preparation of the drug that is less nephrotoxic than conventional AMB, though it is more expensive. It is also a drug of choice for Kala azar.
Nystatin and Hamycin are other Polyenes primarily used topically. Nystatin is specifically indicated for the treatment of oropharyngeal candidiasis.
Systemic Drugs for Systemic Infections: Azoles
Azoles are fungistatic drugs that inhibit the enzyme lanosterol -demethylase. This enzyme is responsible for converting lanosterol into ergosterol, a vital component of the fungal cell membrane. By inhibiting this process, Azoles disrupt membrane integrity.
Ketoconazole is the least potent and most toxic of the Azoles and is not commonly used currently. Its significant side effects include microsomal enzyme inhibition, hepatotoxicity, and the suppression of adrenal steroids. It can also cause gynaecomastia, a side effect shared with other drugs like Digitalis, Spironolactone, and Cimetidine (often remembered by the mnemonic DISK).
Fluconazole is characterized by its maximum oral bioavailability and maximum Central Nervous System (CNS) penetration. It is the drug of choice for the maintenance phase of Candida and Cryptococcus infections. While Amphotericin B is used for the acute phase of Cryptococcal meningitis, Fluconazole is used for the subsequent maintenance or late-shift phase. It is also the drug of choice for initial coverage in certain presentations of Cryptococcal meningitis before shifting to other agents.
Itraconazole is not given intravenously and is the drug of choice for non-serious infections caused by Histoplasma, Sporothrix (sporotrichosis), and Blastomyces (blastomycosis). Voriconazole is the primary drug of choice for invasive aspergillosis. Posaconazole can be administered orally and is used for the treatment of Mucormycosis, although Amphotericin B remains the primary drug of choice for that condition.
Other Systemic Antifungals: 5-Flucytosine and Echinocandins
5-Flucytosine acts by inhibiting DNA polymerase and is typically used in combination with Amphotericin B for the treatment of Cryptococcal meningitis to enhance efficacy.
Echinocandins, such as Caspofungin, Micafungin, and Anidulafungin, represent a class that targets the fungal cell wall. Specifically, they inhibit the synthesis of -1,3-glycan, a critical structural component of the cell wall. Caspofungin is frequently utilized in the treatment of Candida and Aspergilosis infections.